Pulmonary Disease Doctors in Boardman, OH Accepting Medicare

4 Pulmonary Disease doctors found. Showing 1 - 4

Manuel M Bautista, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 960 Windham Ct, Suite 1, Boardman, OH 44512 Phone: 330-726-3357    Fax: 330-726-1465

Dr. Lawrence S Goldstein, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 960 Windham Ct, Suite 1, Boardman, OH 44512 Phone: 330-726-3357    Fax: 330-726-1465

Dr. Nicholas G Proia, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 8423 Market St Ste 100, Boardman, OH 44512 Phone: 330-707-5864    Fax: 330-707-2210

Ritha Kartan, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 960 Windham Ct, Suite 1, Boardman, OH 44512 Phone: 330-726-3357    Fax: 330-726-1465

News Archive

First patient enrolled in type 1 diabetes cell therapy trial

A clinical trial studying the body's ability to fight type 1 diabetes using cell therapy has used the method on its first participant. "The Sanford Project: T-Rex Study" is a collaborative study between Sanford Health and Caladrius Biosciences, Inc., for adolescents with newly onset type 1 diabetes.

Researchers quantify consequences of Ebola outbreak on maternal and child health services

The 2014 Ebola outbreak in West Africa has cost more than 11.000 lives and the health systems in the most affected countries, Guinea, Liberia and Sierra Leone, are still struggling.

Bionomics' BNC210 Phase 1 trial for anxiety and depression meets primary endpoint

Bionomics Limited, a biopharmaceutical company focused on the discovery and development of innovative therapeutics for the treatment of diseases of the central nervous system (CNS) and cancer, today reported positive data from the completed Phase 1 multiple ascending dose, placebo controlled clinical trial of BNC210, an orally administered negative allosteric modulator of the alpha-7 nicotinic acetylcholine receptor (alpha-7 receptor) being developed for the treatment of anxiety and depression.

Sorrento, IGDRASOL to present updates on IG-001 and IG-004 at joint meeting of CLINAM and ETPN

Sorrento Therapeutics, Inc. and IGDRASOL announced today that the companies will present updates of their analyses of proprietary late clinical stage paclitaxel formulations, IG-001 (Cynviloq) and IG-004 (TOCOSOL paclitaxel) at the joint meeting of the European Foundation for Clinical Nanomedicine and the European Technology Platform on Nanomedicine in Basel, Switzerland on June 23 - 26.

Success of health law's exchanges rides on young people

Interviews here with more than two dozen single workers of modest income between 24 and 31 years old suggest that insurance plans will be a hard sell. Subsidies for 26-year-old workers range from $118 a month for someone earning under $16,000 to less than $1 a month for one earning $26,500, according to an analysis of insurance data (Weaver and Radnofsky, 7/25).

Read more Medical News

› Verified 5 days ago